<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
TPST
Tempest Therapeutics
$
()


  • Largest borrow rate increases among liquid names

    4/10/2024 - 08:46am
  • Tempest presents data showing PST-1120 reduces RCC growth as a monotherapy

    4/9/2024 - 08:06am
  • Tempest: Data from Phase 1 trial of TPST-1120 published in journal

    4/4/2024 - 08:12am
  • Scotiabank starts Tempest at Outperform on liver cancer potential

    3/14/2024 - 06:59am
  • Tempest Therapeutics initiated with bullish view at Scotiabank

    3/13/2024 - 16:16pm
  • Tempest Therapeutics presents new data on TPST-1120 at SITC meeting

    3/12/2024 - 08:29am
  • Tempest Therapeutics initiated with bullish view at Jefferies

    2/8/2024 - 06:17am
  • Largest borrow rate increases among liquid names

    1/29/2024 - 08:45am
  • Tempest Therapeutics reports Q3 EPS (48c), consensus (57c)

    11/8/2023 - 17:23pm
  • Four new option listings and nineteen option delistings on October 24th

    10/24/2023 - 08:30am
  • Tempest Therpeutics trading resumes

    10/17/2023 - 09:50am
  • Tempest Therpeutics trading halted, volatility trading pause

    10/17/2023 - 09:44am
  • Tempest Therpeutics trading resumes

    10/12/2023 - 09:42am
  • Tempest Therpeutics trading halted, volatility trading pause

    10/12/2023 - 09:32am
  • Fly Intel: After-Hours Movers

    10/11/2023 - 17:31pm
dynamic_feed Breaking News